{"certainAgreement":{"piSponsorEmployee":false,"restrictiveAgreement":false},"limitationsAndCaveats":{"description":"The study was prematurely terminated due to business reasons. There were no safety concerns that led to study closure. No efficacy assessments and analysis was conducted. A full statistical analysis and report were not completed."},"pointOfContact":{"email":"gajanan.Bhat@sppirx.com","organization":"Spectrum Pharmaceuticals, Inc","phone":"949-743-9219","title":"Gajanan Bhat"}}